Citations

Institution: Mayo Clinic Clear

Showing 10 of 108083 citations.

Artificial Intelligence–Assisted Interpretation of Prostate MRI Improves Cancer Detection
Kurata, Yasuhisa , Takahashi, Naoki

American Journal of Roentgenology | September 17, 2025 | Volume: 226 | Issue: 5 | Pages: No page available

10.2214/ajr.25.33877 | PMID 40960249 Get It

Unmasking the Connection: Cardiac Arrest in Stiff Person Syndrome
Alaws, Hossny, Sujanyal, Saurabh Ashok , Helgeson, Scott A.

No container title available | September 17, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7614528/v1 Get It

Abstract Background: Cardiac arrest, characterized by the sudden loss of heart function, accounts for over 400,000 deaths annually in the United States, often resulting from unwitnessed ventricular arrhythmias. Stiff Person Syndrome (SPS), a rare neurological disorder, is marked by progressive muscle rigidity, painful spasms, which can occasionally lead to autonomic dysfunction and fulminant myocarditis. Case Presentation: We present a rare case of a male patient in his 30s with SPS who developed whole-body spasms, syncope, and respiratory distress. During extubation, he experienced cardiac arrest, requiring advanced cardiac life support (ACLS) and reintubation. Comprehensive evaluations including ECG, cardiac MRI, and laboratory testing suggested autonomic dysfunction and myocarditis as potential contributors to ventricular arrhythmias. Management involved sedation, diazepam, gabapentin, corticosteroids, and implantation of an implantable cardioverter-defibrillator (ICD) for non-sustained ventricular tachycardia. Conclusion: This case highlights the critical need for recognizing cardiac involvement in SPS and emphasizes early diagnosis and intervention to prevent fatal arrhythmias and improve patient outcomes.
Comparative Clinical and Imaging Outcomes of Particulated Juvenile Articular Cartilage Implantation in Shouldered and Unshouldered Patellar Cartilage Lesions With Concomitant Stabilization at 2-Year Follow-up
Davie, Ryann , Ammerman, Brittany , Propp, Bennett E. , Marmor, William A. , Pahapill, Natalie , Kingston, Kiera, Gruber, Simone , Burge, Alissa J. , Wimberly, Audrey , Nguyen, Joseph , Marigi, Erick , Marmor, William , Nguyen, Joseph , Dennis, Elizabeth , Marigi, Erick M. , Stein, Beth E. Shubin

Orthopaedic Journal of Sports Medicine | September 17, 2025 | Volume: 13 | Issue: 9 | Pages: No page available

10.1177/23259671251369018 | PMID 40980560 Get It

Background: Particulated juvenile articular cartilage (PJAC) implantation has demonstrated promising early results in the treatment of symptomatic articular cartilage defects of the patella. However, some uncertainty exists regarding the stability of this cell-based technique in lesions that are not well contained or shouldered. Purpose: To compare clinical and magnetic resonance imaging (MRI) outcomes of PJAC treatment in shouldered versus unshouldered full-thickness cartilage defects of the patella. Study Design: Cohort study; Level of evidence, 3. Methods: A retrospective review of prospectively collected data from an institutional knee registry was conducted to identify patients treated with PJAC for full-thickness symptomatic patellar cartilage lesion between January 2009 and August 2017. Cartilage defects were graded arthroscopically according to the Outerbridge classification and characterized as shouldered or unshouldered. For the primary outcome, postoperative MRI studies were read by a musculoskeletal fellowship-trained radiologist who characterized the percentage of fill based on both coronal and sagittal images. Patient-reported outcome measures (PROMs) were obtained at baseline and 2-year follow-up. MRI and PROM results were compared between the shouldered and unshouldered cohorts. Results: A total of 64 knees in 60 patients (mean age, 26.3 ± 7.6 years) were identified, of which 62 (97%) knees underwent a concomitant patellar stabilization or offloading procedure. There were 32 (50%) shouldered and 32 (50%) unshouldered defects. On postoperative MRI, 68.8% of shouldered lesions demonstrated 67% to 100% fill, compared with 59.4% of unshouldered lesions; 12.5% of shouldered lesions and 15.6% of unshouldered lesions demonstrated 34% to 66% fill; and 18.8% of shouldered lesions and 25.0% of unshouldered lesions demonstrated 0% to 33% fill ( P = .604). At 2 years, significant improvements were observed in Knee Injury and Osteoarthritis Outcome Score (KOOS) Quality of Life (QOL) (23.1 to 65.3; P < .001), International Knee Documentation Committee (IKDC) (41.2 to 76.0; P < .001), KOOS Physical Function Shortform (PS) (34.8 to 13.9; P < .001), Kujala (52.0 to 87.5; P < .001), 12-Item Short Form Survey (SF-12) Physical Health (39.5 to 51.5; P < .001), Veterans Rand 12 Item Health Survey (VR-12) Physical Health (40.7 to 52.8; P < .001), Veterans Rand 6D (0.66 to 0.79; P < .001), SF-12 Mental Health (48.9 to 53.4; P = .015), and VR-12 Mental Health (49.4 to 54.0; P = .019) values. No significant change was observed in Pediatric Functional Activity Brief Scale score (9.1 to 10.3; P = .384). All PROMs were equivalent between shouldered and unshouldered defects at the 2-year follow-up ( P = .318-.980). There was a greater improvement in both KOOS PS (27.2 vs 10.7; P = .015) and Kujala (44.3 vs 26.9; P = .039) values from baseline to the 2-year follow-up in the shouldered group. Conclusion: PJAC implantation with concomitant patellar stabilization led to significantly improved PROMs for both shouldered and unshouldered patellar cartilage lesions over time. Additionally, minimal differences were observed between shouldered and unshouldered defects treated with PJAC at the 2-year follow-up.
Aortitis in Disguise: Cardiomyopathy in a Child With Takayasu Arteritis
Yu, Liwei , Orandi, Amir B. , Hanna, Christian , Niaz, Talha , Hanna, Christian , Orandi, Amir B , Niaz, Talha

Circulation: Cardiovascular Imaging | September 17, 2025 | Volume: 19 | Issue: 1 | Pages: No page available

10.1161/circimaging.125.018497 | PMID 40959893 Get It

Frequency of Seroconversion in Aquaporin‐4 Antibody Testing: Insights From Real‐World Data
Ongphichetmetha, Tatchaporn , Du, Mengke , Vorasoot, Nisa , Pittock, Sean J. , Kunchok, Amy , Pittock, S J , Pittock, Sean J , Vorasoot, Nisa , Cohen, Jeffrey Allen

Annals of Clinical and Translational Neurology | September 17, 2025 | Volume: 12 | Issue: 10 | Pages: 2158-2163

10.1002/acn3.70185 | PMID 40959895 Get It

ABSTRACTClinicians often repeat aquaporin‐4‐immunoglobulin G (AQP4‐IgG) testing in case of possible seroconversion. Compared with older, less sensitive immunofluorescence assays (IFA), cell‐based assays (CBA) offer higher sensitivity. This study assessed the frequency of seroconversion in a retrospective Cleveland Clinic cohort (2006–2024) of 451 patients with an initial negative AQP4‐IgG result who underwent serial testing. Seroconversion occurred in 4.3% (7/170) of patients initially tested by tissue IFA, but in none (0/263) of those tested by CBA. The lack of AQP4‐IgG seroconversion after a negative CBA, with only rare cases after a negative IFA, suggests that repeat AQP4‐IgG testing is low yield unless prior testing used older methods such as IFA.
Neurodevelopment and neural environment inform Alzheimer's disease age at onset and phenotype
Miller, Zachary , Graff‐Radford, Neill R. , Allen, Isabel Elaine , Shwe, Wendy, Rosenberg, Lynne , Olguin, Dustin J., Erkkinen, Michael, Butler, Paul , Yokoyama, Jennifer S. , Desikan, Rahul S. , Rademakers, Rosa , Geschwind, Daniel H. , Kramer, Joel H. , Rosen, Howard J. , Rankin, Katherine P. , Seeley, William W., Sturm, Virginia E. , Miller, Bruce L., Rabinovici, Gil D. , Gorno‐Tempini, Maria Luisa, Miller, Zachary , Yokoyama, Jennifer , Rabinovici, Gil D , Ossenkoppele, Rik , Spina, Salvatore , Scheltens, Philip , Flier, Wiesje M. van der , Pijnenburg, Yolande A.L. , Wolters, Emma E. , Grinberg, Lea T. , Perry, David C. , Gorno‐Tempini, Maria‐Luisa

Alzheimer's & Dementia | September 17, 2025 | Volume: 21 | Issue: 9 | Pages: No page available

10.1002/alz.70668 | PMID 40959879 Get It

Abstract INTRODUCTION Risk factors associated with sporadic non‐amnestic and early‐onset Alzheimer's disease (AD) remain underexamined. METHODS We investigated a large, clinically heterogeneous, AD cohort for frequencies of established risk factors (hypertension, hypercholesterolemia, diabetes mellitus) alongside novel factors (non–right‐handedness, learning disability, seizures, autoimmune disease). RESULTS Early‐onset AD possessed lower frequencies of established risk factors (hypertension, hypercholesterolemia, diabetes mellitus, all p < 0.001) and higher frequencies of novel factors (non–right‐handedness, learning disability, active seizure, all p < 0.001; remote seizure, p = 0.002; and autoimmune disease, p = 0.007). An age at onset < 70 maximally distinguished novel from typical factors. Principal component analysis loaded novel factors into two components, non–right‐handedness and learning disability versus seizure and autoimmune disease, which combined, resulted in an exponential decrease in age at onset from one factor alone. DISCUSSION Identifying novel factors enriched in early‐onset and non‐amnestic AD introduces new theories of AD susceptibility and phenotypic heterogeneity, with significant implications for disease prediction and treatment. Highlights We identified a suite of novel factors overrepresented in early‐onset and non‐amnestic AD. These factors can be broadly conceptualized as neurodevelopmental (non–right‐handedness and learning disability) and neural environmental (seizure and autoimmunity). The combination of these factors produced exponential decreases in AD age at onset, compared to each alone, supporting a new theoretical framework for understanding AD risk with implications for disease prediction, prevention, and therapeutic intervention.
Measuring neurofilament light in human plasma and cerebrospinal fluid: a comparison of five analytical immunoassays
Sheth, Udit , Harrison, Rebecca, Ferber, Kyle , Rosenbaugh, Erin G. , Bevis, Amanda, Khillan, Rohini, Benatar, Michael , Bjorklund, Nicole L. , Daniel, Emeline, Harris, Glenn A., Kahn, Olga I., Liu, Yongge , Zetterberg, Henrik , Mitic, Laura L. , Graham, Danielle , Sheth, Udit , Liu, Yongge, Gendron, Tania F.

Clinical Chemistry and Laboratory Medicine (CCLM) | September 17, 2025 | Volume: 64 | Issue: 2 | Pages: 410-420

10.1515/cclm-2025-0610 | PMID 40958756 Get It

Abstract Objectives Neurofilament light (NfL) is an established biofluid marker of neuroaxonal injury for neurological diseases. Several high-throughput and sensitive immunoassays have been developed to quantify NfL in blood and cerebrospinal fluid (CSF), facilitating the use of NfL as a biomarker in research and clinical practice. However, because of the lack of rigorous comparisons of assays, it has been difficult to determine whether data are comparable and whether assay performance differs. Here, we compared the performance of five NfL immunoassays. Methods To assess the five NfL immunoassays (Fujirebio, ProteinSimple, Quanterix, Roche and Siemens), we used pooled plasma or pooled CSF, as well as unique samples from 20 healthy controls and 20 individuals with El Escorial defined probable or definite amyotrophic lateral sclerosis (ALS), to evaluate precision, parallelism and/or bias. We also examined correlations between plasma and CSF NfL concentrations within and across assays and evaluated their ability to differentiate healthy controls from individuals with ALS. Results Four of the five assays demonstrated exemplary performance based on our analyses of precision and parallelism. Across the five assays, NfL concentrations were lower in plasma than in CSF, although they displayed a high degree of correlation. We noted bias across assays; plasma NfL concentrations were lowest for the Roche assay and highest for the ProteinSimple assay. In addition, all assays reliably distinguished healthy controls from individuals with ALS using plasma or CSF NfL. Conclusions Four NfL assays demonstrated similar analytic performance. Alongside performance, other factors such as costs, accessibility, usability, footprint, and intended use, should be considered.
Prolonged Therapeutic Serum Asparaginase Activity Levels After Administration of Calaspargase Pegol
Martin, Catherine E. , O’Keefe, Madeleine, Gullickson, Taylor, Kohorst, Mira A. , Galardy, Paul J. , McAllister, Linda, Kalmes, Jessica L., Kuhn, Alexis , O'Keefe, Madeleine B, Srinivasan, Anand , Galardy, Paul J , Kuhn, Alexis K , DeFino, Catherine E. , Srinivasan, Anand , McAllister, Linda, Kalmes, Jessica

Pediatric Blood & Cancer | September 17, 2025 | Volume: 72 | Issue: 12 | Pages: No page available

10.1002/pbc.32030 | PMID 40958754 Get It

Automated Prediction of Radiological Protocols Using Retrieval Augmented Generation
Testagrose, Conrad , Korfiatis, Panagiotis , Kline, Timothy L. , Benfield, Justin D., Cook, Cole J. , Merkel, Peggy S., Demirer, Mutlu , Bolan, Candice W. , Erdal, Barbaros S. , Benfield, Justin D., Merkel, Peggy S., White, Richard

No container title available | September 17, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7623430/v1 Get It

Abstract Radiological protocol selection is a critical but time-consuming step in clinical workflow, requiring radiologists to match patient indications with the appropriate MRI or CT protocol. Manual selection can be prone to delays or potential errors, and automated approaches must contend with substantial data imbalance, site-specific variation, and evolving nomenclature. We investigated whether a large language model (LLM) can support reliable protocol selection at scale and whether retrieval-augmented generation (RAG) offers operational advantages over direct fine-tuning. Using 498,228 patient reports collected across three Mayo Clinic sites (Arizona, Florida, and Rochester) spanning six radiological divisions, we trained site-specific Llama 3.2 3B models for use with and without retrieval augmentation. Division-scoped Facebook AI Similarity Search (FAISS) indexes constructed from procedure and diagnosis text were used to supply contextual evidence in the RAG framework. Both fine-tuned and RAG-augmented models achieved strong performance across sites, with F1 scores of 0.88–0.90. RAG matched or modestly trailed direct fine-tuning overall but delivered consistent gains in specific divisions (e.g., musculoskeletal imaging). Importantly, the RAG model introduced abstention behavior (Not Enough Information), which concentrated in linguistically diverse divisions and provided an interpretable signal of uncertainty. These findings suggest that RAG-based models are viable for division-scoped protocol selection and offer practical advantages. Retrieval indexes can be refreshed far more easily and with fewer resources than retraining LLMs, enabling continual adaptation to evolving clinical workflows. Future prospective deployment will evaluate real-time accuracy, agreement with practitioners, and the role of abstention as a safety mechanism in clinical decision support.
Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers
Flagan, Taru , Chu, Stephanie A. , Häkkinen, Suvi , McFall, David , Brown, Jesse A. , Fernhoff, Kristen, Rankin, Katherine P. , Mandelli, Maria Luisa , Gorno‐Tempini, Maria Luisa, Yokoyama, Jennifer S. , Sturm, Virginia E. , Foroud, Tatiana, Geschwind, Daniel H., Ghoshal, Nupur , Graff‐Radford, Neill R., Huang, Eric J. , Huey, Edward D. , Kantarci, Kejal , Mackenzie, Ian R. , Mendez, Mario F. , Onyike, Chiadi U. , Petrucelli, Leonard , Ramos, Eliana Marisa , Roberson, Erik D. , Toga, Arthur W. , Weıntraub, Sandra , Forsberg, Leah K. , Heuer, Hilary W. , Boxer, Adam L., Rosen, Howard J. , Miller, Bruce L., Moreno, Fermín , Seeley, William W., Lee, Suzee E. , Flagan, Taru M , Rohrer, Jonathan D , Kantarci, Kejal , Tartaglia, Maria Carmela , Roberson, Erik , Yokoyama, Jennifer , Zhang, Liwen , Rohrer, Jonathan D. , Lee, Alex J. , Pasquini, Lorenzo , Gorno‐Tempini, Maria‐Luisa, Appleby, Brian S. , Dickerson, Bradford Clark , Domoto‐Reilly, Kimiko , Geschwind, Daniel H. , Graff‐Radford, Neill R. , Hsiung, Ging‐Yuek Robin , Litvan, Irene , Rojas, Julio C. , Boeve, Bradley F. , Boxer, Adam L.

Annals of Clinical and Translational Neurology | September 17, 2025 | Volume: 12 | Issue: 12 | Pages: 2575-2588

10.1002/acn3.70170 | PMID 40958169 Get It

ABSTRACT Objective Autosomal dominant progranulin ( GRN ) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN ‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression. We previously showed that asymptomatic GRN variant carriers exhibit thalamocortical hyperconnectivity that increases with age, presumably as they are approaching symptom onset. Whether hyperconnectivity arises concomitantly with markers of neurodegeneration remains unclear. Methods Utilizing T1 and task‐free functional magnetic resonance imaging from 49 asymptomatic and 26 symptomatic GRN variant carriers, we determined the relationships between functional connectivity, as measured by voxelwise whole‐brain degree, and GRN ‐relevant markers of disease progression, including plasma neurofilament light chain concentrations, cerebrospinal fluid complement C1q and C3b protein levels, obsessive‐compulsive disorder symptom severity, and gray matter volume. Results Neurofilament light chain concentrations were associated with frontotemporoparietal and thalamic hyperconnectivity in asymptomatic GRN variant carriers and extensive regions of atrophy in symptomatic carriers. Complement levels were associated with regions of hyperconnectivity, but not gray matter volume, in symptomatic carriers. Obsessive‐compulsive disorder symptom severity was associated with hypoconnectivity across all GRN carriers. Asymptomatic carriers with thalamic hyperconnectivity tended to have lower gray matter volume in the bilateral insula and left lateral parietal cortex, early regions of atrophy in GRN ‐frontotemporal dementia. Interpretation In asymptomatic carriers, the co‐occurrence of hyperconnectivity, high neurofilament light chain, and low gray matter volume suggests that functional hyperconnectivity may portend the onset of clinical decline. These findings point toward hyperconnectivity as an indicator of approaching symptomatic onset.